Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Lilly answers Novo's GLP-1 pill with FDA nod for Foundayo
The FDA has approved Lilly’s GLP-1 receptor agonist pill under the regulator’s controversial Commissioner's National Priority Voucher program.
Fraiser Kansteiner
Apr 1, 2026 12:40pm
Biogen lays out $5.6B to acquire Apellis
Mar 31, 2026 10:32am
Smarter HCP engagement starts earlier
Brought to you by
Phreesia Network Solutions
Regulatory tracker: Vertex cystic fibrosis meds win wider labels
Apr 1, 2026 10:20am
UK cost watchdog clears Novo's Wegovy for cardio risk reduction
Apr 1, 2026 9:38am
Fierce Biotech
Biopharma layoffs maintain slowdown in Q1
Apr 1, 2026 8:42am
More News
FDA delays decision on Orca Bio’s cell therapy for blood cancers
Apr 1, 2026 8:00am
Evotec adds exec with AI skills to lead rebooted commercial team
Apr 1, 2026 5:38am
Fierce Madness Drug Name Tournament 2026—Final Four voting open
Apr 1, 2026 1:00am
FDA warns of liver safety concerns linked to Amgen's Tavneos
Mar 31, 2026 4:27pm
